The same IL7/IL12 MSCs enhanced the allogeneic response of T cells independently of the CAR implying that IL7/IL12 engineered MSCs booster the specific T cell response and initiate antigen-independent anti-tumor activities. Here, IL7 is linked to neoplasm.